Exploring the mediators that promote carotid body dysfunction in type 2 diabetes and obesity related syndromes

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)
5 Downloads (Pure)

Abstract

Carotid bodies (CBs) are peripheral chemoreceptors that sense changes in blood O2, CO2, and pH levels. Apart from ventilatory control, these organs are deeply involved in the homeostatic regulation of carbohydrates and lipid metabolism and inflammation. It has been described that CB dysfunction is involved in the genesis of metabolic diseases and that CB overactivation is present in animal models of metabolic disease and in prediabetes patients. Additionally, resection of the CB-sensitive nerve, the carotid sinus nerve (CSN), or CB ablation in animals prevents and reverses diet-induced insulin resistance and glucose intolerance as well as sympathoadrenal overactivity, meaning that the beneficial effects of decreasing CB activity on glucose homeostasis are modulated by target-related efferent sympathetic nerves, through a reflex initiated in the CBs. In agreement with our pre-clinical data, hyperbaric oxygen therapy, which reduces CB activity, improves glucose homeostasis in type 2 diabetes patients. Insulin, leptin, and pro-inflammatory cytokines activate the CB. In this manuscript, we review in a concise manner the putative pathways linking CB chemoreceptor deregulation with the pathogenesis of metabolic diseases and discuss and present new data that highlight the roles of hyperinsulinemia, hyperleptinemia, and chronic inflammation as major factors contributing to CB dysfunction in metabolic disorders.

Original languageEnglish
Article number5545
Number of pages21
JournalInternational Journal of Molecular Sciences
Volume21
Issue number15
DOIs
Publication statusPublished - 1 Aug 2020

Keywords

  • Carotid body
  • Glucose
  • Inflammation
  • Insulin
  • Leptin
  • Obesity related syndromes
  • Sympathetic overactivation
  • Type 2 diabetes

Fingerprint Dive into the research topics of 'Exploring the mediators that promote carotid body dysfunction in type 2 diabetes and obesity related syndromes'. Together they form a unique fingerprint.

Cite this